Skip to main content

Advertisement

Log in

Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children

  • Current Topic: Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

In an open multicentre study the efficacy and safety of fluconazole versus ketoconazole were evaluated in the treatment of 46 pediatric patients with oropharyngeal candidiasis and AIDS or HIV infection. Twenty-four subjects received oral fluconazole in a dosage of 3 mg/kg/day and 22 subjects received oral ketoconazole in a dosage of 7 mg/kg/day. The treatment duration ranged from 5 to 49 days. Results showed that fluconazole and ketoconazole have comparable efficacy and safety in the treatment of oropharyngeal candidiasis in HIV-infected children. Patients treated with fluconazole had higher clinical and mycological cure rates at the end of therapy (88 % and 71 % respectively) than those treated with ketoconazole (81 % and 57 % respectively). One case of drug-related side effects (diarrhea and abdominal pain) in a patient receiving ketoconazole resulted in discontinuation of treatment. Follow-up examinations 2 and 4 weeks post-treatment showed a comparably high rate of relapse in both patient groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fleming PL, Gwing M, Oxtoby MJ Epidemiology of HIV infection. In: Yoge R, Connor E (ed): Management of HIV infections in infants and children. CV Mosby, St Louis, 1992, p. 7–22.

    Google Scholar 

  2. Oxtoby MJ Perinatally acquired infection. In: Pizzo P, Wilfert CM (ed): Pediatric AIDS, the challenge of HIV infection in infants, children and adolescents. Williams & Wilkins, Baltimore, 1991, p. 3–20.

    Google Scholar 

  3. Taviatian A, Raufman JP, Rosenthal LE, Weber J, Webber CA, Dincsoy HP Ketoconazole-resistantCandida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology 1986, 90: 443–445.

    PubMed  Google Scholar 

  4. Lewis JH, Zimmerman HJ, Benson GD, Ishak KG Hepatic injury associated with ketoconazole therapy. Gastroenterology 1984, 86: 503–513.

    PubMed  Google Scholar 

  5. Lazar JD, Hilligoss DM The clinical pharmacology of fluconazole. Seminars in Oncology 1990, 17, Supplement 6: 14–18.

    Google Scholar 

  6. Centers for Disease Control Classification for human immunodeficiency virus infection in children under 13 years of age. Morbidity and Mortality Weekly Report 1987, 36: 225–230, 235–236.

    Google Scholar 

  7. Hay RJ Overview of studies of fluconazole in oropharyngeal candidiasis. Reviews of Infectious Diseases 1990, 12, Supplement 3: 334–337.

    Google Scholar 

  8. Dupont B, Drouhet E Fluconazole in the management of oropharyngeal candidiasis in a predominantly HIV-antibody-positive group of patients. Journal of Medical and Veterinary Mycology 1988, 26: 67–71.

    PubMed  Google Scholar 

  9. Koletar SL, Russel JA, Fass RJ, Plouffe JF Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 1990, 34-11: 2267–2268.

    PubMed  Google Scholar 

  10. De Wit S, Weerts D, Goossens H, Clumeck N Comparison of fluconazole and ketoconazole for treatment of oropharyngeal candidiasis in AIDS and ARC patients. Lancet 1989, i: 746–747.

    Article  Google Scholar 

  11. Bunnin N Oral fluconazole for treatment of disseminated fungal infections. Pediatric Infectious Disease Journal 1989, 8: 62.

    Google Scholar 

  12. Shojiro A, Kosei I Experience of fluconazole in pediatric patients. Japanese Journal of Antibiotics 1989, 170: 170.

    Google Scholar 

  13. Viscoli C, Castagnola E, Fioredda F, Ciravegna B, Barigione G, Terragna A Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrobial Agents and Chemotherapy 1991, 35: 365–367.

    PubMed  Google Scholar 

  14. Gil A, Lavilla P, López Dupla M, Valencia E, Pintado V, Khamashta M, Garcia Puing J, Ortiz Vasquez J Tratamiento de la candidiasis esofagica con fluconazol en el síndrome de la inmunodeficiencia adquirida. Estudio comparativo de dos pautas terapeúticas. Medicina Clinica 1992, 98: 612–617.

    PubMed  Google Scholar 

  15. Lavilla P, Gil A, Valencia E, Pintado V, Lopez Dupla M, Kamashta M, Garcia Puig J, Ortiz Vasquez J Profilaxis secundaria de la candidiasis esofagica con fluconazol en el síndrome de immunodeficiencia adquirida. Revista Clinica Espanola 1992, 190: 115–119.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Additional information

A. Roberts, J. Tricoire, Hôpital Purpan, Toulouse, France; D.M. Gibb, H. Holzel, V.M. Novelli, The Hospitals for Sick Children, London, UK; M.I. de Jose, Hospital Infantil La Paz, Madrid, Spain; B. Perez-Gorricho, Hospital Niño Jesus, Madrid, Spain; C. Fortuny-Guasch, Hospital Clinico y Provincial, Barcelona, Spain; A. Mur-Sierra, Hospital Nuestra Señora del Mar, Barcelona, Spain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hernández-Sampelayo, T., a Multicentre Study Group. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Eur. J. Clin. Microbiol. Infect. Dis. 13, 340–344 (1994). https://doi.org/10.1007/BF01974616

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01974616

Keywords

Navigation